← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Louisiana State University Health Sciences Center New Orleans
$12,058,536
Total funding
18
Grants
Funding over time
peak $3.3M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
DOD$12,062,369 · 17
DOE$-3,833 · 1
By mechanism
—$12,058,536 · 18
Investigators at Louisiana State University Health Sciences Center New Orleans
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
INTRAMEDULLARY CALCIUM SULFATE ANTIBIOTIC DEPOT FOR PREVENTION OF OPEN FRACTURE-RELATED INFECTION: A RANDOMIZED CLINICAL TRIAL$2,242,893
· FY2022 · Defense Health Agency
¿¿HYPERBARIC OXYGEN THERAPY IN THE TREATMENT OF CHRONIC MILD-MODERATE BLAST-INDUCED TRAUMATIC BRAIN INJURY PCS AND PTSD"$2,108,000
· FY2010 · Department of Defense
MIRNA-RELATED POLYGENIC RISK SCORE AND MIRNA EXPRESSION ON PROSTATE CANCER SURVIVAL IN WHITES AND BLACKS$1,167,053
· FY2025 · Defense Health Agency
ENDOCANNABINOIDS AS A TARGET FOR THE TREATMENT OF TRAUMATIC BRAIN INJURY$777,197
· FY2011 · Department of Defense
DRUG DISCOVERY OF BAX ACTIVATORS FOR THE TREATMENT OF BREAST CANCER$758,753
· FY2017 · Department of the Army
NEUROMODULATION PROMOTES TISSUE REGENERATION OVER FIBROSIS$724,860
· FY2021 · Defense Health Agency
INTRAOSSEOUS ANTIBIOTIC FOR POINT-OF-CARE WOUND PROPHYLAXIS$723,066
· FY2022 · Defense Health Agency
CLINICAL DEVELOPMENT OF ISGYLATION DIAGNOSTIC BIOMARKER FOR ALS$717,334
· FY2025 · Defense Health Agency
ALCOHOL INTOXICATION IMPACT ON OUTCOME FROM TRAUMATIC INJURY$618,527
· FY2008 · Department of Defense
HGF/C-MET PATHWAY IN AIDS-RELATED LYMPHOMA$525,600
· FY2015 · Department of the Army
PROTECT THE FRACTURE: BONE AND HARDWARE BACTERIAL BIOFILM DISPERSAL WITH ENZYMATIC DEBRIDEMENT$377,932
· FY2025 · Defense Health Agency
IDENTIFICATION OF A NEW DRUG TO TREAT POLYCYSTIC KIDNEY DISEASE$294,000
· FY2022 · Defense Health Agency
NOVEL DNA REPAIR-INDEPENDENT ROLES OF DNA-PKCS IN HYPERCHOLESTEROLEMIA-INDUCED ATHEROSCLEROSIS$292,521
· FY2025 · Defense Health Agency
MONOCLONAL ANTIBODY-BASED THERAPIES FOR DISSEMINATED CANDIDIASIS$292,000
· FY2018 · Department of the Army
TARGETING THE HOST IMMUNE RESPONSE IN COVID-19 VIA ADENOSINE-MEDIATED IMMUNOMODULATION$277,340
· FY2021 · Defense Health Agency
A MEDITERRANEAN DIET TO CONTROL BREAST CANCER PROGRESSION TO BONE$109,843
· FY2008 · Department of the Army
FATTY ACID SYNTHASE ACTIVITY AS A TARGET FOR C-MET-DRIVEN PROSTATE CANCER$55,450
· FY2011 · Department of Defense
BUILDING TO SUPPORT CANCER RESEARCH AND PREVENTION$-3,833
· FY2012 · Department of Energy